VTYXVentyx Biosciences, Inc.

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20M

Net Income

-$20M

EPS (Diluted)

$-0.39

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$262M

Total Liabilities

$19M

Stockholders' Equity

$243M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$20M	-$11M	-82.4%
Net Income	-$20M	-$16M	-28.7%

VTYX Q2 2022 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena